INCY ▲ +0.2% - Incyte Corporation $INCY Q3 2026: Total revenue $1.56b, up 14% YoY Net sales $1.32b, up 14% YoY Jakafi $827m, up 4% Opzelura $255m, up 36% Hematology/Oncology $235m, up 38% Raising FY26 guidance across portfolio 29-OCT-2026 07:07 AM ET